Press "Enter" to skip to content

New patent expiration for Abbvie Inc drug ORIAHNN (COPACKAGED)

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug ORIAHNN (COPACKAGED)

Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29

Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

This drug has forty-two patent family members in twenty-four countries.

The generic ingredient in ORIAHNN (COPACKAGED) is elagolix sodium,estradiol,norethindrone acetate; elagolix sodium. One supplier is listed for this compound. Additional details are available on the elagolix sodium,estradiol,norethindrone acetate; elagolix sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug ORIAHNN (COPACKAGED)

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions